Managed by NetworkPharma

Managed by

Facilitating Networking and Information Sharing amongst Pharmaceutical and MedComms, Medical Communications, Medical Education and Medical Publishing Specialists

This global initiative facilitates networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities.
Why not sign up to our weekly newsletter and please, help spread the word amongst all relevant others.


  • Home
  • About us
  • Testimonials
  • Events
  • Useful Reading
  • In the News
  • Companies
  • Independents
  • Services
  • Special offers
  • Job Adverts
  • Twittering
  • Webcasts
  • Starting out
  • Weekly Newsletter
  • Weekly Comment
  • Survey data
  • Sponsors

  • MedComms Networking on Facebook

    MedComms Networking on Linkedin

    MedComms Networking on Twitter

    MedComms Networking on YouTube

    MedComms Networking is sponsored by:

    Many thanks to all the Sponsors of MedComms Networking


    Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.

    MedComms Networking - 12 November 2019


    When 'medical education' is mentioned, many people think immediately of continuing medical education (CME), but the remit can be much broader, encompassing areas such as product-specific medical education and disease awareness activities. In last week's webinar, Leigh van Wyk, Tracey Wood and Phil Loder of Ogilvy Health looked at the latest thinking and best practice in medical education, covering topics such as pharma standards, needs assessments, principles of adult learning, and measurement of outcomes. The video recording is now freely available to everyone, everywhere.

    As mentioned in the recording, this position paper from 2017 is worth reading.

    Tamara Allen, Nina Donde, Eva Hofstädter-Thalmann, Sandra Keijser, Veronique Moy, Jean-Jacques Murama and Thomas Kellner (2017) Framework for industry engagement and quality principles for industry-provided medical education in Europe, Journal of European CME, 6:1, DOI: 10.1080/21614083.2017.1348876

    So, next on the agenda for our weekly #MedComms webinars is Working in MedComms at McCann Health Medical Communications, tomorrow at the usual time of 12.00 UK time. Phil Hall, Recruitment Manager at McCann Health Medical Communications will talk about the company, what MedComms means for them and the different roles within their teams. He'll explain what they look for in entry-level staff, what training is provided and what are the career prospects across the group. It should be of interest to anyone who's looking for insights in to MedComms as a career and how to maximise their chances of gaining an entry-level job. Please help spread the word amongst all relevant others.

    And next week we're joined by Lauri Arnstein, Patient Partnership Liaison at Envision Pharma Group for Patient involvement in scientific communications. As part of her role at Envision the Patient, Lauri leads their Plain Language Unit and is committed to guiding teams across Envision to develop clear, accessible and relevant scientific content. She will talk about patient involvement in medicines development, focusing on results reporting and publications and, importantly, patient authorship. It should be of interest to anyone working in and around MedComms who is interested in why and how to ethically and effectively involve patients in publications. Please join us.

    On related notes, if you missed them in the past few days, the following provide useful reading for your next coffee break.

    Where next for patient centricity in pharma? in pharmaphorum, which starts; "As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need to consider to deliver on its promises."

    Reporting research findings to participants is an ethical imperative, an editorial in the BMJ, states; "The results of clinical trials should be disseminated to those who took part in them. For a start, it is a basic courtesy, and that should be reason enough. It is also an ethical imperative." Hear hear. But haven't we been talking about this for rather a long time? Progress seems slow.

    Remember, details of all our activities are kept bang up-to-date at or give me a shout at any time if you've any questions, comments or suggestions.


    Peter Llewellyn
    Managing Director, NetworkPharma Ltd
    Follow me on Twitter @NetworkPharma
    Join 4,000 international colleagues in the MedComms Networking Linkedin Group
    The information at is always bang up-to-date!


    Subscribe to the weekly MedComms Networking email newsletter here - it's entirely free of charge!

    This web site and associated activities are being managed by NetworkPharma Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, UK
    Telephone +44 (0) 1865 784390 Email:

    Our web sites

    [] [] [] []
    [] [] []
    [] [] []